Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Bioequivalence Study of Vortioxetine Hydrobromide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions

Bai W, Song H, Hu Y, Zhang X, Wang X, Guo C, Qiu B, Dong Z

Drug Design, Development and Therapy 2023, 17:3035-3046

Published Date: 29 September 2023

Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy

Miura I, Horikoshi S, Ichinose M, Suzuki Y, Watanabe K

Drug Design, Development and Therapy 2023, 17:3023-3031

Published Date: 28 September 2023

Macro, Micro, and Nano-Inspired Bioactive Polymeric Biomaterials in Therapeutic, and Regenerative Orofacial Applications

Atia GA, Shalaby HK, Roomi AB, Ghobashy MM, Attia HA, Mohamed SZ, Abdeen A, Abdo M, Fericean L, Bănățean Dunea I, Atwa AM, Hasan T, Mady W, Abdelkader A, Ali SA, Habotta OA, Azouz RA, Malhat F, Shukry M, Foda T, Dinu S

Drug Design, Development and Therapy 2023, 17:2985-3021

Published Date: 27 September 2023

Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method

Liu X, Ju G, Yang W, Chen L, Xu N, He Q, Zhu X, Ouyang D

Drug Design, Development and Therapy 2023, 17:2955-2967

Published Date: 27 September 2023


Read more articles